General Health

COVID-19 Update

COVID-19 Update

Thankfully, it would seem that British Columbia is ahead of “the curve” for COVID-19 mitigation and that our efforts are paying off as we head into warmer whether. Unfortunately, the same cannot be said for Ontario and Quebec, as well as New York state and New Jersey, but there is a light at the end of those tunnels too and…

Learn More

COVID-19 Update

COVID-19 Update

Yesterday, after I sent out an essential email closure letter to my clients encouraging people to try and stay home and follow proper hygiene procedures, while outlining the current statistical modelling for COVID-19, I received an email from a client that was concerned about fear mongering. But with spring break coming to a close and many Canadians returning home, it…

Learn More

COVID-19

COVID-19

With the Canadian government considering invoking the Emergencies Act and much of the world on lock down, the majority of us can’t help but focus on our families, regardless of our personal feelings about the COVID pandemic. In my demographic, age 43, my biggest concerns about the reported epidemiology of COVID-19 falls to the older generation. I also cannot help…

Learn More

Social Responsibility – Remote Consults – Novel Coronavirus (Covid-19)

Social Responsibility – Remote Consults – Novel Coronavirus (Covid-19)

Recent concerns over the Coronavirus has lead to some social unrest, confusion and uncertainty in our communities. These feelings have created fear (and panic in some cases) about the medical consequences surrounding this pandemic and the general health and safety of our loved ones.  With any novel (new) infection there is reason for uncertainty but the epidemiology surrounding this infection…

Learn More

Peptides Anyone? GLP-1 receptor agonists

Peptides Anyone? GLP-1 receptor agonists

Once again, the A4M (Advancement for Anti-Aging Medicine) Conference in December of 2019 did not disappointment. The advancements in functional medicine treatments and assessments for prolonging life, assessing the causes of autoimmune disease, and addressing cardiovascular disease risk never cease to amaze me. Modern biological medicines first came on the market in 1982 with the development of human insulin. From…

Learn More